Nexvet Biopharma plc
SEC CIK 1618561 · NVET · last insider filing 2017-08-02
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Patel Rajiv A | Director | filed 2015 - 2017 |
| Payne John Bernard | Director | filed 2015 - 2017 |
| Brown Christopher Nigel | Director | filed 2015 - 2017 |
| Hanna Ashraf | Director | filed 2015 - 2017 |
| Heffernan Mark | Director · Chief Executive Officer | filed 2015 - 2017 |
| Kilty Cormac G | Director | filed 2015 - 2017 |
| Mccracken Joseph S | Director | filed 2015 - 2017 |
| Gunn George W | Director | filed 2015 - 2017 |
| Wald Graeme | Director | filed 2015 - 2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Lismore Damian T. | Chief Financial Officer | filed 2015 - 2017 |
| Farrell Geraldine T | VP, Operations & G.C. | filed 2015 - 2017 |
| Horn Jurgen | Chief Product Development Ofcr | filed 2015 - 2017 |
| Gearing David | Chief Scientific Officer | filed 2015 - 2016 |
| Giles Colin | VP, Clinical & Reg. Affairs | filed 2015 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.